Brightpoint (CELL) Guides Q4, FY12
Tweet
Share
E-mailGet Alerts CELL Hot Sheet
Price: $1.00 --0%
Financial Fact:
Total gross profit: 85.67M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total gross profit: 85.67M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Brightpoint (Nasdaq: CELL) sees Q4 adj-EPS of 30-35 cents, vs. the consensus of 32 cents.
Sees FY12 EPS of $1.08-$1.20, vs. the consensus of $1.16.
Sees FY12 EPS of $1.08-$1.20, vs. the consensus of $1.16.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
